what is a natural glp-1 agonist America's Poison Centers Mapping the effectiveness and risks
Description
The Medicines and Healthcare products Regulatory Agency (MHRA) has warned healthcare professionals to be aware of the potential risk of pulmonary aspiration in patients using glucagon-like peptide-1 (GLP-1) or dual glucose-dependent insulinotropic polypeptide (GIP)/GLP-1 receptor agonists (GLP-1 RAs), who undergo surgery or procedures with general anaesthesia or deep sedation
HOW TO USE: Spritz up your gut health routine with a delicious dose of daily fiber
In a recent study, researchers found that GLP-1RA medications such as Ozempic and Wegovy are associated with a higher risk of post-endoscopy aspiration pneumonia.
Berberine (BBR) exhibits significant anti-diabetic effects by enhancing insulin sensitivity, promoting glycolysis, and inhibiting gluconeogenesis
The global GLP-1 market is estimated to grow from USD 49.3 billion in the current year to USD 157
Compounded semaglutide/tirzepatide will phase out by late May 2025, so prepare to switch to FDA-approved products
